Table 4.
Odds ratios of renal disease from a multiple regression model
| Variable | Adjusted ORa | 95% CIb | P value |
|---|---|---|---|
| PPIc use |
1.72 |
(1.27-2.32) |
< 0.001 |
| NSAIDd use |
1.64 |
(1.35-2.00) |
< 0.001 |
| Antibiotic use |
3.66 |
(2.86-4.68) |
<0.001 |
| Diuretic use |
2.28 |
(1.78-2.92) |
<0.001 |
| Diabetes |
2.74 |
(2.09-3.60) |
< 0.001 |
| Hypertension |
1.51 |
(1.21-2.89) |
< 0.001 |
| High cholesterol |
1.10 |
(0.89-1.37) |
0.388 |
| Myocardial infarction |
0.63 |
(0.21-1.89) |
0.409 |
| Congestive heart failure |
9.51 |
(3.90-23.20) |
< 0.001 |
| Cerebrovascular disease |
3.65 |
(1.28-10.43) |
0.016 |
| Peripheral vascular |
4.20 |
(1.83-9.66) |
< 0.001 |
| Paralysis |
1.37 |
(0.25-7.34) |
0.717 |
| Chronic lung disease |
1.81 |
(1.03-3.17) |
0.040 |
| Liver disease |
7.38 |
(2.88-18.91) |
< 0.001 |
| Malignancy |
3.72 |
(2.07-6.70) |
< 0.001 |
| Metastatic cancer |
8.86 |
(3.35-23.44) |
< 0.001 |
| Rheumatoid arthritis |
2.62 |
(0.97-7.13) |
0.058 |
| Osteoarthritis | 0.83 | (0.60-1.21) | 0.373 |
aOR odds ratio.
bCI confidence interval.
cPPI proton pump inhibitor.
dNSAID nonsteroidal anti-inflammatory drugs.